The Journal of Urology
Volume 185, Issue 4 , Pages 1388-1393, April 2011

Regular Nonsteroidal Anti-Inflammatory Drug Use and Erectile Dysfunction

  • Joseph M. Gleason

      Affiliations

    • Department of Urology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
    • Corresponding Author InformationCorrespondence: Department of Urology, Kaiser Permanente, LAMC, 4900 Sunset Blvd., 2nd Floor, Los Angeles, California 90027
  • ,
  • Jeffrey M. Slezak

      Affiliations

    • Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, California
  • ,
  • Howard Jung

      Affiliations

    • Department of Urology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
  • ,
  • Kristi Reynolds

      Affiliations

    • Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, California
  • ,
  • Stephen K. Van Den Eeden

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • Financial interest and/or other relationship with Takada and GlaxoSmithKline.
  • ,
  • Reina Haque

      Affiliations

    • Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, California
  • ,
  • Virginia P. Quinn

      Affiliations

    • Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, California
  • ,
  • Ronald K. Loo

      Affiliations

    • Department of Urology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
  • ,
  • Steven J. Jacobsen

      Affiliations

    • Department of Research and Evaluation, Kaiser Permanente Southern California, San Diego, California
    • Financial interest and/or other relationship with Kaiser Permanente and Merck.

Received 20 January 2010 published online 21 February 2011.

Purpose

Previous data suggest a potential relationship between inflammation and erectile dysfunction. If it is causal, nonsteroidal anti-inflammatory drug use should be inversely associated with erectile dysfunction. To this end we examined the association between nonsteroidal anti-inflammatory drug use and erectile dysfunction in a large, ethnically diverse cohort of men enrolled in the California Men's Health Study.

Materials and Methods

This prospective cohort study enrolled male members of the Kaiser Permanente managed care plans who were 45 to 69 years old beginning in 2002. Erectile dysfunction was assessed by questionnaire. Nonsteroidal anti-inflammatory drug exposure was determined by automated pharmacy data and self-reported use.

Results

Of the 80,966 men in this study 47.4% were considered nonsteroidal anti-inflammatory drug users based on the definitions used and 29.3% reported moderate or severe erectile dysfunction. Nonsteroidal anti-inflammatory drug use and erectile dysfunction strongly correlated with age with regular drug use increasing from 34.5% in men at ages 45 to 49 years to 54.7% in men 60 to 69 years old with erectile dysfunction increasing from 13% to 42%. The unadjusted OR for the association of nonsteroidal anti-inflammatory drugs and erectile dysfunction was 2.40 (95% CI 2.27, 2.53). With adjustment for age, race/ethnicity, smoking status, diabetes mellitus, hypertension, hyperlipidemia, peripheral vascular disease, coronary artery disease and body mass index, a positive association persisted (adjusted OR 1.38). The association persisted when using a stricter definition of nonsteroidal anti-inflammatory drug exposure.

Conclusions

These data suggest that regular nonsteroidal anti-inflammatory drug use is associated with erectile dysfunction beyond what would be expected due to age and comorbidity.

Key Words:  penis , erectile dysfunction , anti-inflammatory agents , non-steroidal , age factors , comorbidity

Abbreviations and Acronyms:  AMI, acute myocardial infarction , BMI, body mass index , CAD, coronary artery disease , CMHS, California Men's Health Study , COX, cyclooxygenase , ED, erection dysfunction , KP, Kaiser Permanente Medical Care Program , NSAID, nonsteroidal anti-inflammatory drug

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received approval from Kaiser Permanente Northern California and Southern California institutional review boards.

 Supported by the California Cancer Research Program (99-86883) and Kaiser Foundation Community Benefit Program.

PII: S0022-5347(10)05203-1

doi:10.1016/j.juro.2010.11.092

The Journal of Urology
Volume 185, Issue 4 , Pages 1388-1393, April 2011